AI summary by TwinMind
Leadership in the Age of AI | Paul Hudson and Lindsay Levin | TED
TED
17m 34s
AI Implementation at Sanofi
- Goal: become world's leading pharmaceutical company using AI at scale
- Current usage statistics:
- 23,000 people using AI monthly
- 9,000 people using AI daily
- Strategy: "all in" approach to fourth Industrial Revolution
- Objective: provide daily decision intelligence to give people nudges, deeper insights, increased effectiveness
- CEO surprised by executive focus on governance/controls rather than opportunity
- Comparison to historical technology adoption (internet, cell phones)
Organizational Transformation Through AI
- Radical data transparency implementation
- Real-time data access at all organizational levels
- CEO gets same data/insights simultaneously as lower-level employees
- Eliminates traditional slide deck preparation/story crafting process
- Data accuracy approach: make live data correct rather than wait for perfection
- Younger talent empowerment:
- Junior employees (2-4 years experience) included in senior discussions
- "Inverted pyramid" structure
- Younger staff claiming better AI insights than senior executives
Impact on Workforce and Job Evolution
- AI adoption not primarily about job elimination
- Focus on creating more meaningful work
- Shift from Excel/PowerPoint/Word to insights and action
- Productivity gains lead to employees volunteering for additional responsibilities
- Less data crunching, more interpretation and insight work
- Historical parallel: similar resistance occurred with internet and cell phone adoption
Sustainability Initiatives
- Evolution from "poster by elevator" to active involvement
- Healthcare industry carbon footprint equals airline industry
- 50% from drug manufacturing/shipping, 50% from healthcare delivery
- Specific example: pre-diabetic intervention
- Healthy adult: 16 tons carbon lifetime
- Diabetic adult: 48 tons carbon lifetime (3X difference)
- Collaboration with King Charles and Sustainable Markets Initiative
- Cross-industry cooperation (Novo Nordisk, AstraZeneca, GSK)
- Focus on decarbonizing healthcare delivery
- Plastic removal from vaccine/medicine packaging (regulatory challenges)
Leadership in Complex Social Issues
- Employee expectations for company values alignment increasing
- Challenges with polarized social issues (50/50 employee splits)
- Strategy: focus on enabling 99,000 employees to "live best version of themselves"
- Inclusion priorities: race, LGBTQ+, various diversity issues
- Core principle: healthcare mission enables best life possible
- Acknowledgment that perfection impossible on all issues
Perma-Crisis Leadership Model
- CEO role transformation since late 2019
- Continuous crisis management: pandemic, Russia-Ukraine war, Israel-Hamas conflict, China-US tensions
- Leadership requirements:
- Resiliency and agility
- Open-mindedness
- Recognition of expertise limitations
- Trust in ground-level team advice
- People protection and relocation capabilities
- Dual focus: business fundamentals + crisis response
- Non-negotiable: continued medicine development and global distribution regardless of politics
AI-Driven Innovation Examples
- Large language models transforming drug discovery
- Revisiting previously failed medicines with enhanced data analysis
- Employee engagement survey analysis:
- 409,000 comments, 9 million words
- 40-minute AI analysis vs traditional slide deck approach
- Clear identification of top 3 loved/hated company aspects
- Applications in structural biology and electromicroscopy
- Targeting previously "undruggable" targets
- Elimination of "heavy lifting unglamorous work"
- R&D reinvestment opportunities
- Competitive advantage through bold AI adoption while competitors focus on governance
